Leigh Cantrell
LC

Leigh Cantrell

Associate Professor
Unit: School of Medicine
Department: Department of Obstetrics and Gynecology
Office location and address
Emily Couric Clinical Cancer Center
81 Hospital Dr
Charlottesville, Virginia 22903
Education
BS, University of North Carolina at Chapel Hill
MS, Public Health, University of North Carolina at Chapel Hill
MD, University of North Carolina at Chapel Hill
Residency, Obstetrics and Gynecology, University of North Carolina at Chapel Hill
Fellowship, Gynecology and Oncology, University of North Carolina at Chapel Hill
Biography

Dr. Leigh Cantrell treats women with gynecologic malignancies, including both surgical treatments and chemotherapy. She is an associate professor in the Division of Gynecologic Oncology and serves as the Obstetrics and Gynecology Residency Program Director. She is board-certified in obstetrics and gynecology and gynecologic oncology.

Dr. Cantrell completed her undergraduate studies, medical degree, Master of Science in Public Health, residency in obstetrics and gynecology and fellowship in gynecologic oncology at the University of North Carolina at Chapel Hill. Her fellowship training included extensive training in robotic surgery and her robotic surgery skills were of special interest when she was recruited to join the faculty at UVA in 2010. She serves as chair of the Robotic Surgeon's Group at University Hospital.

As a gynecologic oncologist, the nature of the treatment plans Dr. Cantrell develops for her patients often create a long-lasting patient-physician bond — an element of her role that she finds deeply fulfilling.

A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
Source: University Of Oklahoma
June 18, 2018 – June 30, 2022
MD-OBGY Determining the Sensitivitiy of Sentinel Lymph Nodes Identified with Robotic Flourescence Imaging for Detecting Metastatic Endometrial and Cervical Cancer
Source: Trustees of Indiana University
July 15, 2013 – April 30, 2015
MD-OBGY Randomized Phase II Evaluation of Carboplatin/Paclitaxel with and without Trastuzumab (Herceptin) in Her2/neu+ Patients with Advanced/Recurrent Uterine Serous Papillary Carcinoma
Source: Yale University
April 15, 2013 – April 15, 2015
  • 2013-2018 Best Doctors in America® List